PNPanli Ni

Panli Ni

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Panli Ni has a total of 22 co-authors. Here are the top co-authors by number of shared publications:

  • Chunmei Gong

    Key Laboratory of Tropical Translational Medicine of Ministry of Education & Key Laboratory of Brain Science Research and Transformation in Tropical Environment of Hainan Province, School of Basic Medicine and Life Sciences, Hainan Medical University, Haikou, Hainan, China

    1 shared publication
  • Fabiao Yu

    Hainan Medical University

    1 shared publication
  • Fengxin Xiao

    Hainan General Hospital, Hainan Medical University, Haikou, Hainan, China

    1 shared publication
  • Juan Wang

    Key Laboratory of Tropical Translational Medicine of Ministry of Education & Key Laboratory of Brain Science Research and Transformation in Tropical Environment of Hainan Province, Hainan Provincial Stem Cell Research Institute, School of Basic Medicine and Life Sciences, Hainan Medical University, Haikou, 571199, China

    1 shared publication
  • Juan Wang

    Key Laboratory of Tropical Translational Medicine of Ministry of Education & Key Laboratory of Brain Science Research and Transformation in Tropical Environment of Hainan Province, School of Basic Medicine and Life Sciences, Hainan Medical University, Haikou, Hainan, China

    1 shared publication
  • Pengbing Hua

    Engineering Research Center for Hainan Bio-Smart Materials and Bio-Medical Devices, Key Laboratory of Hainan Functional Materials and Molecular Imaging, College of Emergency and Trauma, Hainan Academy of Medical Sciences, Hainan Medical University, Haikou, 571199, China

    1 shared publication

Latest Publications

  • Top Cited Papers
    Open Access

    Immunoregulatory orchestrations in osteoarthritis and mesenchymal stromal cells for therapy

    by Tongmeng Jiang, Shibo Su, Ruijiao Tian, Yang Jiao, Shudan Zheng, Tianyi Liu, Yang Yu, Pengbing Hua, Xiuhong Cao, Yanlong Xing, et al.


  • Curcumin's multi-target mechanisms in the treatment of Alzheimer's disease and creative modification techniques

    by Xiaoyuan Meng, Yong Gong, Fengxin Xiao, Zhao Cao, Zheyu Zhuang, Xinan Yi, Juan Wang, Renjun Feng, Chunmei Gong, Panli Ni

    Alzheimer's disease (AD) is a well-established neurodegenerative disorder characterized by memory impairment, cognitive dysfunction, and behavioral disturbances. With the global population aging, the prevalence of AD continues to rise, presenting significant challenges to both society and healthcare systems. Curcumin, a polyphenolic compound derived from turmeric rhizomes, has demonstrated considerable potential in AD treatment due to its anti-inflammatory, antioxidant, and neuroprotective properties. However, its clinical application remains constrained by chemical instability, poor water solubility, rapid metabolism, and accelerated elimination. To overcome these limitations, various curcumin derivatives have been synthesized, and combination therapy strategies have been explored. This review examines the potential mechanisms through which curcumin may exert therapeutic effects in AD, including the inhibition of neuroinflammation, regulation of tau protein hyperphosphorylation, modulation of amyloid-β peptides, and provision of antioxidant benefits. Additionally, the advantages of curcumin derivatives and combination therapy approaches are discussed, offering novel perspectives and promising strategies for AD treatment. It is anticipated that advancements in drug design and therapeutic approaches will contribute to the development of more effective treatment options for AD.